South China Morning Post CENTER (0.0) Reliability: 7.5/10

Mirxes wins China’s approval to launch groundbreaking blood test for gastric cancer

✍️ Eric Ng 📅 October 09, 2025 01:03 PM 🕐 Scraped: October 09, 2025

Summary: The non-invasive blood test helps in the early detection of the fifth leading cause of cancer deaths globally.

Cancer screening device developer Mirxes Holding has won approval from Beijing to launch a gastric cancer test, the first blood test for the disease in China’s vast oncology diagnost

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Eric Ng

Original Publisher

🌍 South China Morning Post

CENTER Bias (0.0)

Published Date

October 09, 2025 at 01:03 PM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only